catalyst · primary record
ENTRESTO
Patent expiry · 2026-11-08 · SACUBITRIL; VALSARTAN
| Company | NOVARTIS PHARMACEUTICALS CORP |
|---|---|
| Ticker | Not stated |
| Impact | high |
| Detail | US 9388134 expires · SACUBITRIL; VALSARTAN |
| Source | FDA Orange Book |
Provenance
- Source: FDA Orange Book
- Fetched at: 2026-10-28T10:36:56.929Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NOVARTIS PHARMACEUTICALS CORP:ENTRESTO:2026-11-08:US 9388134 expires · SACUBITRIL; VALSARTAN
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.